GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhejiang Ausun Pharmaceutical Co Ltd (SHSE:603229) » Definitions » Price-to-Funds-From-Operations

Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Price-to-Funds-From-Operations : (As of Apr. 28, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Zhejiang Ausun Pharmaceutical Co Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Zhejiang Ausun Pharmaceutical Co (SHSE:603229) Business Description

Traded in Other Exchanges
N/A
Address
No.5, Donghai 4th Avenue, chemical raw materials base Linhai Park East, Zhejiang Province, Taizhou, CHN, 317016
Zhejiang Ausun Pharmaceutical Co Ltd is mainly engaged in the research and development, production and sales of specialty APIs and pharmaceutical intermediates, as well as providing customized production and research for customers. Its products portfolio includes Prostaglandins and their intermediates, Raw material medicine, Fluorine series and Develop products.